Conexiant
Login
  • Corneal Physician
  • Glaucoma Physician
  • New Retinal Physician
  • Ophthalmology Management
  • Ophthalmic Professional
  • Presbyopia Physician
  • Retinal Physician
The Ophthalmologist
  • Explore

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Anterior Segment
    • Glaucoma
    • Retina

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Cataract
    • Cornea
    • Glaucoma
    • Neuro-ophthalmology
    • Oculoplastics
    • Optometry
    • Pediatric
    • Retina
  • Business

    Business & Profession

    • Professional Development
    • Business and Entrepreneurship
    • Practice Management
    • Health Economics & Policy
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
Subscribe
Subscribe

False

Advertisement
The Ophthalmologist / Issues / 2026 / February / UK: More than a Million Over 40s Living with Glaucoma
Glaucoma Latest News

UK: More than a Million Over 40s Living with Glaucoma

New modeling data estimate higher glaucoma prevalence in the UK, with cases expected to increase over the coming decades

2/20/2026 2 min read

Share

  • Full Article
  • Summary
  • Takeaways
  • Listen
  • Report
  • Scorecard
  • Quiz
  • Poll
  • Top Institutions

Clinical Report: More than a Million Over 40s Living with Glaucoma

Overview

Revise to explicitly connect the projected increase to demographic changes and underdiagnosis.

Background

Glaucoma is a chronic eye disease that can lead to irreversible vision loss, often without early symptoms. The rising prevalence of glaucoma poses significant public health challenges, necessitating improved detection and management strategies. Understanding the demographics and risk factors associated with glaucoma is crucial for healthcare providers to address this growing concern effectively.

Data Highlights

Current estimates indicate that approximately 1.1 million adults over 40 in the UK have glaucoma, with a projected increase of 60% by 2060. The prevalence among adults over 85 is estimated at 11%, and 4% among individuals of African descent.

Key Findings

  • Over 1 million people aged 40+ in the UK currently live with glaucoma.
  • Projected cases of glaucoma are expected to rise to 1.6 million by 2060.
  • Approximately 500,000 individuals are believed to have undiagnosed glaucoma.
  • Late diagnosis is linked to a higher risk of avoidable vision loss in over 40% of patients.
  • Non-European ethnic groups account for a disproportionate percentage of current glaucoma cases.

Clinical Implications

Healthcare professionals should prioritize early detection and treatment of glaucoma to mitigate the risk of vision loss. Increased awareness and expanded diagnostic capacity are essential to manage the anticipated rise in glaucoma cases effectively.

Conclusion

The significant increase in glaucoma prevalence highlights the urgent need for enhanced screening and management strategies in the UK. Addressing this public health issue is critical to preserving vision and improving patient outcomes.

References

  1. Moorfields Eye Hospital, British Journal of Ophthalmology, 2026 -- More than a Million Over 40s Living with Glaucoma
  2. The Ophthalmologist, 2026 -- Rethinking UK Glaucoma Care
  3. The Ophthalmologist, 2026 -- Why Glaucoma Prevalence Is Rising
  4. Ophthalmology Management, 2016 -- Glaucoma’s growing prevalence in the US
  5. NICE, 2025 -- Glaucoma: diagnosis and management
  6. Glaucoma Physician — Glaucoma in Africa
  7. Glaucoma Clinical science Current burden and futur
  8. Glaucoma: diagnosis and
  9. Clinical Application of the 20-Year Results from the Ocular Hypertension Treatment Study - PubMed

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.

Related Content

Newsletters

Receive the latest Ophthalmology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

False

Advertisement

False

Advertisement

Explore More in Ophthalmology

Dive deeper into the world of Ophthalmology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement
The Ophthalmologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.

Affiliations:

Specialties:

Areas of Expertise:

Contributions:

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: